Original Article

You have full text access to this OnlineOpen article

Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients

A metaanalysis

  1. Amy C. Degnim M.D.1,†,*,
  2. Kent A. Griffith M.P.H., M.S.2,
  3. Michael S. Sabel M.D.1,
  4. Daniel F. Hayes M.D.3,
  5. Vincent M. Cimmino M.D.1,
  6. Kathleen M. Diehl M.D.1,
  7. Peter C. Lucas M.D.4,
  8. Matthew L. Snyder M.D.4,
  9. Alfred E. Chang M.D.1,
  10. Lisa A. Newman M.D., M.P.H.1

Article first published online: 7 OCT 2003

DOI: 10.1002/cncr.11803

Issue

Cancer

Cancer

Volume 98, Issue 11, pages 2307–2315, 1 December 2003

Additional Information

How to Cite

Degnim, A. C., Griffith, K. A., Sabel, M. S., Hayes, D. F., Cimmino, V. M., Diehl, K. M., Lucas, P. C., Snyder, M. L., Chang, A. E. and Newman, L. A. (2003), Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer, 98: 2307–2315. doi: 10.1002/cncr.11803

Author Information

  1. 1

    Department of Surgery, University of Michigan, Ann Arbor, Michigan

  2. 2

    Department of Biostatistics, University of Michigan, Ann Arbor, Michigan

  3. 3

    Department of Medicine, University of Michigan, Ann Arbor, Michigan

  4. 4

    Department of Pathology, University of Michigan, Ann Arbor, Michigan

  1. †

    Fax: (507) 284-5196

*Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905

Publication History

  1. Issue published online: 17 NOV 2003
  2. Article first published online: 7 OCT 2003
  3. Manuscript Accepted: 22 AUG 2003
  4. Manuscript Revised: 20 AUG 2003
  5. Manuscript Received: 11 JUN 2003

Funded by

  • Fashion Footwear Association of New York (FFANY)/QVC presents/Shoes on Sale®

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (214K)

REFERENCES

  • 1
    Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001; 92: 1368–1377.
    Direct Link:
  • 2
    Kakuda JT, Stuntz M, Trivedi V, Klein SR, Vargas HI. Objective assessment of axillary morbidity in breast cancer treatment. Am Surg. 1999; 65: 995–998.
  • 3
    Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg. 1999; 229: 536–541.
  • 4
    Liang WC, Sickle-Santanello BJ, Nims TA. Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am J Surg. 2001; 182: 365–368.
  • 5
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22: 719–748.
  • 6
    Abdessalam SF, Zervos EE, Prasad M, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg. 2001; 182: 316–320.
  • 7
    Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol. 2001; 8: 145–149.
  • 8
    Rahusen FD, Torrenga H, van Diest PJ, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg. 2001; 136: 1059–1063.
  • 9
    Wong SL, Edwards MJ, Chao C, et al. Predicting the status of the nonsentinel axillary nodes: a multicenter study. Arch Surg. 2001; 136: 563–568.
  • 10
    Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer. 2000; 89: 574–581.
    Direct Link:
  • 11
    Hwang RF, Krishnamurthy S, Hunt K, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003; 10: 248–254.
  • 12
    Reynolds C, Donohue JH, Grant CS, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol. 1999; 17: 1720–1726.
  • 13
    Cserni G. Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla. Eur J Surg Oncol. 2001; 27: 532–538.
  • 14
    Kamath VJ, Giuliano R, Dauway EL, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla. Arch Surg. 2001; 136: 688–692.
  • 15
    Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A. Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol. 2002; 28: 623–626.
  • 16
    Canavese G, Gipponi M, Catturich A, et al. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients. J Surg Oncol. 2001; 77: 81–87.
    Direct Link:
  • 17
    Den Bakker MA, van Weeszenberg A, de Kanter AY, et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol. 2002; 55: 932–935.
  • 18
    Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer. 2001; 92: 1378–1384.
    Direct Link:
  • 19
    Sachdev U, Murphy K, Derzie A, Jaffer S, Bleiweiss IJ, Brower S. Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg. 2002; 183: 213–217.
  • 20
    Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 1997; 226: 271–278.
  • 21
    Sabel MS, Zhang P, Barnwell JM, Winston JS, Hurd T, Edge SB. Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma. J Surg Oncol 2001; 77: 243–246.
    Direct Link:
  • 22
    Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol. 1999; 6: 756–761.
  • 23
    Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001; 92: 748–752.
    Direct Link:
  • 24
    Grube BJ, Giuliano AE. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 2001; 20: 230–237.
    Direct Link:
  • 25
    Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer. 2002; 94: 2542–2551.
    Direct Link:
  • 26
    Bevilacqua JL, Manasseh DE, Kattan MW, et al. A multivariate nomogram to predict likelihood of non-sentinel node metastases in breast cancer patients with positive sentinel nodes [abstract]. Presented at the Society of Surgical Oncology, Los Angeles, California, March 6–9, 2003.
  • 27
    Guenther JM, Hansen NM, DiFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg. 2003; 138: 52–56.
  • 28
    Greco M, Agresti R, Cascinelli N, et al. Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg. 2000; 232: 1–7.
  • 29
    Bland KI, Scott-Conner CE, Menck H, Winchester DP. Axillary dissection in breast-conserving surgery for Stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg. 1999; 188: 586–596.
  • 30
    Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival–a Bayesian meta-analysis. Ann Surg Oncol. 1999; 6: 109–116.
  • 31
    Morrow M. A survival benefit from axillary dissection: was Halsted correct? Ann Surg Oncol. 1999; 6: 17–18.
View Full Article (HTML) Get PDF (214K)